The Antianginal Agent, Ranolazine, Reduces Myocardial Infarct Size but Does Not Alter Anatomic No-Reflow or Regional Myocardial Blood Flow in Ischemia/Reperfusion in the Rabbit.
Hale, Sharon L. BS; Kloner, Robert A. MD, PhD, FACC
[Article] Journal of Cardiovascular Pharmacology & Therapeutics. 13(3):226-232, August 2008.

(Format: HTML, PDF)